B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CASP7

MOLECULAR TARGET

caspase 7

UniProt: AAP35329NCBI Gene: 84033 compounds

CASP7 (caspase 7) is targeted by 33 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CASP7

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Disulfiram1.795
2Astemizole Antihistamine drug now withdrawn from1.614
3Dactinomycin1.614
4Celecoxib1.393
5Lovastatin1.393
6Aprepitant1.102
7Bortezomib1.102
8Daunorubicin1.102
9Ethinyl Estradiol1.102
10Methylcholanthrene1.102
11o-Phthalaldehyde1.102
12Potassium Dichromate Chromic acid (H2Cr2O7), dipotassium salt.1.102
13Thioridazine1.102
14Atorvastatin0.691
15myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
16Cetylpyridinium Cationic bactericidal surfactant used as0.691
17Dasatinib0.691
18Isopentenyladenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is0.691
19Lithocholic Acid0.691
20Lumefantrine0.691
21Maprotiline0.691
22Melphalan0.691
23Mometasone Furoate0.691
24ninhydrin0.691
25Nocodazole Nocodazole is0.691
26oxatomide [Supplementary Concept] structure;0.691
27Oxymetholone0.691
28Perphenazine0.691
29Promethazine0.691
30Reserpine0.691
31Retinaldehyde0.691
32Safrole0.691
33triflupromazine hydrochloride0.691

About CASP7 as a Drug Target

CASP7 (caspase 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 33 compounds with documented CASP7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CASP7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.